AAVXF
Price
$6.91
Change
+$1.02 (+17.32%)
Updated
Mar 10 closing price
Capitalization
394.46M
RENB
Price
$0.52
Change
+$0.02 (+4.00%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
81.29M
Ad is loading...

AAVXF vs RENB

Header iconAAVXF vs RENB Comparison
Open Charts AAVXF vs RENBBanner chart's image
Abivax SA
Price$6.91
Change+$1.02 (+17.32%)
Volume$200
Capitalization394.46M
Renovaro
Price$0.52
Change+$0.02 (+4.00%)
Volume$8.36K
Capitalization81.29M
AAVXF vs RENB Comparison Chart
Loading...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. RENB commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and RENB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (AAVXF: $6.91 vs. RENB: $0.50)
Brand notoriety: AAVXF and RENB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 68% vs. RENB: 46%
Market capitalization -- AAVXF: $394.46M vs. RENB: $81.29M
AAVXF [@Biotechnology] is valued at $394.46M. RENB’s [@Biotechnology] market capitalization is $81.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileRENB’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • RENB’s FA Score: 0 green, 5 red.
According to our system of comparison, both AAVXF and RENB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RENB’s TA Score shows that 4 TA indicator(s) are bullish.

  • RENB’s TA Score: 4 bullish, 7 bearish.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while RENB (@Biotechnology) price change was -24.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

RENB is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($394M) has a higher market cap than RENB($81.3M). AAVXF YTD gains are higher at: -37.466 vs. RENB (-40.084).
AAVXFRENBAAVXF / RENB
Capitalization394M81.3M485%
EBITDAN/A-115.96M-
Gain YTD-37.466-40.08493%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A312K-
Total DebtN/A6.37M-
FUNDAMENTALS RATINGS
AAVXF vs RENB: Fundamental Ratings
AAVXF
RENB
OUTLOOK RATING
1..100
4263
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AAVXF's Valuation (74) in the null industry is in the same range as RENB (98) in the Financial Conglomerates industry. This means that AAVXF’s stock grew similarly to RENB’s over the last 12 months.

AAVXF's Profit vs Risk Rating (100) in the null industry is in the same range as RENB (100) in the Financial Conglomerates industry. This means that AAVXF’s stock grew similarly to RENB’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as RENB (99) in the Financial Conglomerates industry. This means that AAVXF’s stock grew similarly to RENB’s over the last 12 months.

AAVXF's Price Growth Rating (63) in the null industry is in the same range as RENB (65) in the Financial Conglomerates industry. This means that AAVXF’s stock grew similarly to RENB’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as RENB (100) in the Financial Conglomerates industry. This means that AAVXF’s stock grew similarly to RENB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RENB
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNCRY28.380.32
+1.14%
UniCredito Spa
DRCR0.06N/A
N/A
Dear Cashmere Holding Co.
NDBKY14.05-0.08
-0.57%
Nedbank Group, Ltd.
SSDOY18.90-0.16
-0.84%
Shiseido Company, Ltd.
LOMLF0.21N/A
-2.28%
Lion One Metals Ltd.

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
N/A
CNSP - AAVXF
34%
Loosely correlated
-5.15%
ACHV - AAVXF
28%
Poorly correlated
-5.99%
RENB - AAVXF
26%
Poorly correlated
-7.84%
More

RENB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-7.84%
VRCA - RENB
37%
Loosely correlated
N/A
DTIL - RENB
36%
Loosely correlated
-5.87%
TNGX - RENB
34%
Loosely correlated
-6.57%
AAVXF - RENB
26%
Poorly correlated
N/A
QSI - RENB
26%
Poorly correlated
N/A
More